Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
451
datasets available to search
ShareScore release 0.9.0
Dataset results
451 results for “AMD”
Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
ClinicalTrials.gov study NCT00858208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00056823. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
ClinicalTrials.gov study NCT05593913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD
ClinicalTrials.gov study NCT00499590. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03972709. IPD Sharing: YES. Countries: 1. Publications: 0.
Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00931489. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00414206. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00775411. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03452527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD
ClinicalTrials.gov study NCT01495221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT02914639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD
ClinicalTrials.gov study NCT01958918. IPD Sharing: NO. Countries: 10. Publications: 0.
Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD
ClinicalTrials.gov study NCT00446654. IPD Sharing: Not stated. Countries: 3. Publications: 0.
To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD
ClinicalTrials.gov study NCT00612456. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03539549. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00251459. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.
ClinicalTrials.gov study NCT00321997. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
ClinicalTrials.gov study NCT01256580. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03197493. IPD Sharing: NO. Countries: 1. Publications: 0.
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
ClinicalTrials.gov study NCT00492284. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.